[go: up one dir, main page]

AU2002341281A1 - A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine - Google Patents

A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine

Info

Publication number
AU2002341281A1
AU2002341281A1 AU2002341281A AU2002341281A AU2002341281A1 AU 2002341281 A1 AU2002341281 A1 AU 2002341281A1 AU 2002341281 A AU2002341281 A AU 2002341281A AU 2002341281 A AU2002341281 A AU 2002341281A AU 2002341281 A1 AU2002341281 A1 AU 2002341281A1
Authority
AU
Australia
Prior art keywords
diacetoxy
propoxymethyl
guanine
acetyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002341281A
Inventor
Jayachandra Suresh Babu
Chandras Has Khanduri
Yatendra Kumar
Purna Chandra Ray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2002341281A1 publication Critical patent/AU2002341281A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
AU2002341281A 2001-10-15 2002-10-15 A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine Abandoned AU2002341281A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1050/DEL/01 2001-10-15
IN1050DE2001 2001-10-15
PCT/IB2002/004235 WO2003033498A2 (en) 2001-10-15 2002-10-15 A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine

Publications (1)

Publication Number Publication Date
AU2002341281A1 true AU2002341281A1 (en) 2003-04-28

Family

ID=11097126

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002341281A Abandoned AU2002341281A1 (en) 2001-10-15 2002-10-15 A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine

Country Status (4)

Country Link
US (1) US20050176956A1 (en)
EP (1) EP1453833A2 (en)
AU (1) AU2002341281A1 (en)
WO (1) WO2003033498A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003278420A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
WO2004048380A1 (en) * 2002-11-22 2004-06-10 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
WO2011114336A1 (en) * 2010-03-15 2011-09-22 Hetero Research Foundation Process for the isolation of ganciclovir intermediate
CN104761552B (en) * 2015-03-06 2016-08-24 常州康丽制药有限公司 A kind of processing method of ganciclovir condensation substance isomer
CN113929580B (en) * 2021-10-29 2024-10-18 湖北省宏源药业科技股份有限公司 Method for recovering side chains in ganciclovir condensate mother liquor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US5792868A (en) * 1991-09-18 1998-08-11 Ajinomoto Co., Inc. Process for producing acyclic nucleosides and process for separating purine nucleosides
FI961054A7 (en) * 1993-09-10 1996-03-07 Recordati S A Chemical And Process for the preparation of 9-(2-hydroxy)ethoxymethylguanine
US5583225A (en) * 1994-05-17 1996-12-10 University Of Georgia Research Foundation, Inc. Syntheses of acyclic guanine nucleosides
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
IN179493B (en) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
EP0806425B1 (en) * 1996-04-09 2001-08-29 Lupin Laboratories Limited An improved regiospecific process for synthesis of acyclic nucleosides
AU2003278420A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
WO2004048380A1 (en) * 2002-11-22 2004-06-10 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir

Also Published As

Publication number Publication date
US20050176956A1 (en) 2005-08-11
WO2003033498A2 (en) 2003-04-24
EP1453833A2 (en) 2004-09-08
WO2003033498A3 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
GB2380562B (en) Model-free adaptation of a process controller
AU2001242496A1 (en) Process for the production of a titanium silicalite shaped body
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
IL157709A0 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
IL162188A0 (en) Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
AU2002341281A1 (en) A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine
AU2002365372A1 (en) New process
AU2002310898A1 (en) Process for the preparation of a polymer-amine
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
HUP0401390A3 (en) Process for the manufacture of homopolyamide-4,6 fibers
HUP0401989A3 (en) A process for the preparation of the 14 beta-hydroxy-baccatin iii-1,14-carbonate
AUPR573601A0 (en) Novel process
AU2003269482A1 (en) Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
AU2002344500A1 (en) A process for preparing 2,6-dichloropurine
AU2002339579A1 (en) A process for the preparation of 3,4,5-trifluoronitrobenzene
AU2002312320A1 (en) Process for the treatment of a fiber
AUPS260702A0 (en) Process for the preparation of 2,6-difluoropurines
AUPR526001A0 (en) Process for the preparation of 2,6-difluoropurines
AU2002316070A1 (en) Process for purifying titanium tetrachloride
AU2003260745A1 (en) Sulphonylamino derivatives for the treatment of alzheimer's disease
AU2002324469A1 (en) Substituted-heteroaryl-7-aza(2.2.1)bicycloheptanes for the treatment of disease
AU2001249997A1 (en) Offshootfund investment process
AU2002312109A1 (en) Process for the production of nylon 6
AU2003207264A1 (en) Process for producing pyridoxine-5'-alpha-glucoside

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase